UBS Group »

Coeptis Therapeutics Hldgs I shares owned by UBS Group

Quarter-by-quarter ownership of Coeptis Therapeutics Hldgs I (COEP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Coeptis Therapeutics Hldgs I

Jan 2025Feb 2025Mar 2025Apr 2025May 2025Jun 2025Jul 2025020k40k60k80k02000400060008000
Value ($)Share countHistorical COEP position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Coeptis Therapeutics Hldgs I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coeptis Therapeutics Hldgs I by UBS Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $640 82 7.80
2025-03-31 $78k 8.6k 9.00
2024-12-31 $37k 6.8k 5.50

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Coeptis Therapeutics Hldgs I

Vanguard Group
Geode Capital Management
Steward Partners Investment Advisory
Tower Research Capital
UBS Group
Barclays
Raymond James Financial

View all funds holding Coeptis Therapeutics Hldgs I